ClinicalTrials.Veeva

Menu

The Investigation of Predicting Mortality and Morbidity in Patients Admitted to Intensive Care Unit With Thoracic Trauma Using Selected Biomarkers and Parameters

S

Suleyman Demirel University

Status

Completed

Conditions

Thorax Traumas

Treatments

Diagnostic Test: blood sampling

Study type

Observational

Funder types

Other

Identifiers

NCT06930222
SENCER-CELIK-001

Details and patient eligibility

About

This prospective study aimed to predict morbidity and mortality after thoracic trauma in intensive care unit evaluated clinical and biochemical data of 50 intensive care unit patients. The research examined demographic factors such as gender, age, and smoking status, trauma scoring systems like ISS and RTS as well as biomarkers such as Surfactant-d and oxygenation parameters including the ROX index, PaO₂/FiO₂ ratio and FiO₂.

Enrollment

50 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with thoracic trauma between the ages of 18-85
  • Patients who have been monitored in intensive care for at least 1 week

Exclusion criteria

  • Being outside the age range of 18-85
  • Pregnant patients
  • Patients whose intensive care follow-up lasted less than 1 week
  • Patients who do not want to be included in the study
  • Patients with a lung malignancy diagnosis before admission

Trial design

50 participants in 1 patient group

thorax trauma patients
Description:
thorax trauma patients admitted to icu
Treatment:
Diagnostic Test: blood sampling

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems